Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

By Issue

Search Results

##search.searchResults.foundPlural##

Methotrexate in the therapeutic pathway of patients with psoriasis. Analysis of clinical practice data and comparison with guidelines

Valeria Corazza, Francesco Cusano, Ornella De Pità, Luigi Rossi, G. Giovanni Virno

28-12-2021

https://doi.org/10.4081/dr.2022.9454

4113

PDF: 665

APPENDIX: 172

HTML: 15
Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies

Edoardo Mortato, Silvia Baratta, Luca Rubino, Anna Paola De Caro, Francesco Loconsole

19-06-2023

https://doi.org/10.4081/dr.2023.9755

851

PDF: 415

HTML: 17
Combination of cyclosporine A and methylprednisolone to treat pediatric Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome

Shinta Trilaksmi Dewi, Laily Noor Qomariah, Widya Khairunisa Sarkowi, Monika Puspitasari, Miya Khalidah, Marcella Anggatama, Dwinanda Almira Rizkiani, Kristiana Etnawati, Sri Awalia Febriana

19-06-2023

https://doi.org/10.4081/dr.2023.9656

1276

PDF: 634

HTML: 183
Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło

22-05-2023

https://doi.org/10.4081/dr.2023.9630

1058

PDF: 563

HTML: 73
Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients

Martina Burlando, Mattia Fabio Molle, Emanuele Cozzani, Aurora Parodi

14-03-2022

https://doi.org/10.4081/dr.2022.9091

2625

PDF: 632

HTML: 6
Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero

17-03-2022

https://doi.org/10.4081/dr.2022.9282

1162

PDF: 825

HTML: 41
Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

Viviana Lora, Dario Graceffa, Monia Di Prete, Carlo Cota

11-11-2024

https://doi.org/10.4081/dr.2024.10140

989

PDF: 521

SUPPLEMENTARY MATERIAL: 153

HTML: 16
Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

19-05-2023

https://doi.org/10.4081/dr.2023.9692

1057

PDF: 546

HTML: 19
Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces

Martina Vispi, Teresa Corradin, Camilla Peccianti, Luca Feci, Laura Casini, Chiara Pisani, Susanna Fabbroni, Paola Corsetti, Margherita Croatto, Michele Pellegrino

25-06-2020

https://doi.org/10.4081/dr.2020.8642

1352

PDF: 751

HTML: 8
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

13-09-2023

https://doi.org/10.4081/dr.2023.9839

2686

PDF: 982

HTML: 31
Erythrodermic psoriasis improved by tildrakizumab

Giampaolo Trevisan, Lerica Germi, Luigi Naldi

23-11-2022

https://doi.org/10.4081/dr.2022.9448

1139

PDF: 620

HTML: 21
LASMIK laser biorevitalization: mechanisms and therapeutic experience

Sergey Vladimirovich Moskvin, Aleksandr Agubechirovich Khadartsev

28-12-2020

https://doi.org/10.4081/dr.2020.8996

1625

PDF: 448

HTML: 27
Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data

Aikaterini Kyriakou, Anastasia Trigoni, Nikiforos Galanis, Dimitrios Sotiriadis, Aikaterini Patsatsi

01-10-2018

https://doi.org/10.4081/dr.2018.7859

1980

PDF: 1055

HTML: 63
A microRNA focus on acne

Sarah Gordon, Alison M. Layton, Sandra Fawcett, Kehinde Ross

02-02-2024

https://doi.org/10.4081/dr.2024.9902

1081

PDF: 717

HTML: 57
Asian herbal medicine for atopic dermatitis: a systematic review

Nikko Vanda Limantara, Ronggo Sadono, Suci Widhiati, Retno Danarti

25-08-2023

https://doi.org/10.4081/dr.2023.9727

1701

PDF: 807

HTML: 34
Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

Paolo Dapavo, Matteo Megna, Marina Talamonti

09-08-2024

https://doi.org/10.4081/dr.2024.9999

1739

PDF: 669

HTML: 94
Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

Gioele Ghezzi, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

12-11-2024

https://doi.org/10.4081/dr.2024.10080

1172

PDF: 659

HTML: 27
Telangiectasia Macularis Eruptiva Perstans: more than skin deep

Casey E. Watkins, Winston B. Bokor, Stuart Leicht, George Youngberg, Guha Krishnaswamy

e12

29-07-2011

https://doi.org/10.4081/dr.2011.e12

11687

PDF: 2218

HTML: 2302
Post-inflammatory hyperpigmentation after carbon dioxide laser: review of prevention and risk factors

Alhanouf Bin Dakhil, Asem Shadid, Saad Altalhab

19-05-2023

https://doi.org/10.4081/dr.2023.9703

4784

PDF: 937

APPENDIX 1: 142

HTML: 49
Skin reaction to COVID-19 vaccine: a report of 4 cases

Mariabeatrice Bertolani, Maria Beatrice de Felici del Giudice, Erminia Ridolo, Francesco Pucciarini, Claudio Feliciani, Francesca Satolli

12-07-2022

https://doi.org/10.4081/dr.2022.9376

1097

PDF: 472

HTML: 14
Treatment satisfaction among patients with psoriasis in Saudi Arabia

Mahdi Aldhafiri, Rahaf Almutairi, Reem Albejais, Asma Almubark, Hussain Alwesaibie, Mohammed Albesher, Manayer Almustihi

15-04-2024

https://doi.org/10.4081/dr.2024.9967

1039

PDF: 553

HTML: 29
Refractory pityriasis rubra pilaris treated with abrocitinib

Filip Rob

09-01-2025

https://doi.org/10.4081/dr.2025.10105

406

PDF: 273

HTML: 11
Atopic dermatitis: a brief review of recent advances in its management

Sultan Daghafak Alenazi

23-05-2023

https://doi.org/10.4081/dr.2023.9678

2393

PDF: 1409

HTML: 106
Delayed diagnosis of adult indolent systemic mastocytosis

Carsten Sauer Mikkelsen, Andrew Nybo, Kristian Bakke Arvesen, Johan Holk-Poulsen

17-02-2014

https://doi.org/10.4081/dr.2014.5199

3309

PDF: 879

HTML: 2122
Autoinflammatory diseases: what is behind them and what is new?

Michele Maalouly, Serena Saade, Mazen Kurban

29-12-2022

https://doi.org/10.4081/dr.2023.9625

1792

PDF: 563

HTML: 138

1 - 25 of 39 items 1 2 > >>

Search

Search Results

Methotrexate in the therapeutic pathway of patients with psoriasis. Analysis of clinical practice data and comparison with guidelines

Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies

Combination of cyclosporine A and methylprednisolone to treat pediatric Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome

Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients

Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces

Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Erythrodermic psoriasis improved by tildrakizumab

LASMIK laser biorevitalization: mechanisms and therapeutic experience

Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data

A microRNA focus on acne

Asian herbal medicine for atopic dermatitis: a systematic review

Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

Telangiectasia Macularis Eruptiva Perstans: more than skin deep

Post-inflammatory hyperpigmentation after carbon dioxide laser: review of prevention and risk factors

Skin reaction to COVID-19 vaccine: a report of 4 cases

Treatment satisfaction among patients with psoriasis in Saudi Arabia

Refractory pityriasis rubra pilaris treated with abrocitinib

Atopic dermatitis: a brief review of recent advances in its management

Delayed diagnosis of adult indolent systemic mastocytosis

Autoinflammatory diseases: what is behind them and what is new?

authors

reviewers

Categories

indexing

dermatopathology